temozolomide has been researched along with u 0126 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ali-Osman, F; Augustine, CK; Beasley, GM; Burchette, J; Jung, SH; McMahon, N; Padussis, J; Pruitt, SK; Selim, MA; Toshimitsu, H; Tyler, DS; Yoo, JS; Yoshimoto, Y; Zipfel, PA | 1 |
Banerjee, R; Belinsky, G; Huang, Y; Jean-Claude, BJ; McNamee, JP; Qiu, Q | 1 |
Amaral, CL; Arjmand, N; Ashouri-Sanjani, M; Azimi, P; Brahmbhatt, P; Braverman, V; Bu, X; Chao, M; Clement, C; Contieri, LS; Costa, SO; Dai, L; Dong, W; Dou, W; Drineas, P; Edmonds, CR; Elnahas, T; Enterline, L; Feng, L; Fields, KG; Fragomen, A; Fusco, NM; Galal, S; Gao, J; Guo, K; Hamilton, A; Han, L; Harris, SN; He, X; Hinkley, J; Hu, Y; Huang, Q; Igboechi, O; Ignacio-Souza, LM; James, EW; Khabyeh-Hasbani, N; Lamplot, JD; Lawton, CD; Liguori, GA; Liu, W; Liu, Y; Lotfy, R; Lu, H; Madhusudhan, T; Martins, ICA; Meaney, CJ; Mehta, R; Meng, X; Milanski, M; Mohammadi-Moghadam, S; Musco, C; Ortolan, SC; Pearle, AD; Premkumar, A; Principe, P; Qu, X; Rasheed, MA; Rozbruch, SR; Salama, E; Salama, S; Salem, SM; Schultz, K; Sharaf, M; Shen, L; Shin, J; Souza, ACP; Sun, W; Thurnherr, E; Torsoni, AS; Torsoni, MA; Upadhyay, J; Wang, H; Wang, L; Wang, M; Wang, T; Wei, X; Woodruff, DP; Wu, J; Xie, Y; Yang, X; Zeng, H; Zhang, J; Zhang, W; Zhong, X; Zhou, S | 1 |
1 review(s) available for temozolomide and u 0126
2 other study(ies) available for temozolomide and u 0126
Article | Year |
---|---|
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Blotting, Western; Butadienes; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Melanoma; Melphalan; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Nitriles; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rats; Rats, Nude; Sorafenib; Temozolomide; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle.
Topics: Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; DNA Damage; DNA Methylation; Drug Synergism; Enzyme Activation; ErbB Receptors; Gefitinib; Humans; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylation; Quinazolines; Signal Transduction; Temozolomide; Triazenes | 2011 |